| Identification | Back Directory | [Name]
Propanamide, 2-[[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]amino]-, (2S)- | [CAS]
1894207-44-3 | [Synonyms]
Tisolagiline
Tisolagiline (KDS2010)
Tisolagiline (Synonyms: KDS2010)
Propanamide, 2-[[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]amino]-, (2S)- | [Molecular Formula]
C17H17F3N2O | [MOL File]
1894207-44-3.mol | [Molecular Weight]
322.32 |
| Chemical Properties | Back Directory | [Boiling point ]
443.9±45.0 °C(Predicted) | [density ]
1.220±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
16.01±0.50(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Tisolagiline (KDS2010) is a reversible MAO-B inhibitor used in Parkinson's disease research[1]. | [References]
[1] Nam MH, et al. KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson's Disease. Neurotherapeutics. 2021 Jul;18(3):1729-1747. DOI:10.1007/s13311-021-01097-4 |
|
|